Patients with severe obstructive sleep apnea syndrome and elevated high-sensitivity C-reactive protein need priority treatment

Otolaryngology - Head and Neck Surgery

Volumn 143, Issue 1, 2010, Pages 72-77

  Lee, Li Ang ^a   Chen, Ning Hung ^a   Huang, Chung Guei ^a   Lin, Shih Wei ^a   Fang, Tuan Jen ^a   Li, Hsueh Yu ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CORRELATION COEFFICIENT; DIABETES MELLITUS; EPWORTH SLEEPINESS SCALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NOSE ALLERGY; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; PRIMARY MEDICAL CARE; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME; SMOKING; TONSIL;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; HUMANS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; POLYSOMNOGRAPHY; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; TAIWAN;

EID: 77953677010     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2010.04.001     Document Type: Article

References (27)

1. Chuang L.P., Hsu S.C., Lin S.W., et al. Prevalence of snoring and witnessed apnea in Taiwanese adults. Chang Gung Med J 31 (2008) 175-181
2. McNicholas W.T., Bonsignore M.R., and Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29 (2007) 156-178
3. Sorajja D., Gami A.S., Somers V.K., et al. Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest 133 (2008) 927-933
4. Drager L.F., Bortolotto L.A., Lorenzi M.C., et al. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172 (2005) 613-618
5. Lévy P., Pépin J.L., Arnaud C., et al. Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives. Eur Respir J 32 (2008) 1082-1095
6. Khot U.N., Khot M.B., Bajzer C.T., et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290 (2003) 898-904
7. Rogowski O., Shapira I., Toker S., et al. Obesity-related correlation between C-reactive protein and the calculated 10-y Framingham Coronary Heart Disease Risk Score. Int J Obes 29 (2005) 772-777
8. Sattar N., Murray H.M., McConnachie A., et al. C-reactive protein and prediction of coronary heart disease and global vascular events in the prospective study of Pravastatin in the elderly at risk (PROSPER). Circulation 115 (2007) 981-989
9. Shamsuzzaman A.S.M., Winnicki M., Lanfranchi P., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105 (2002) 2462-2464
10. Punjabi N.M., and Beamer B.A. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 30 (2007) 29-34
11. Barceló A., Barbé F., Llompart E., et al. Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med 117 (2004) 118-121
12. Guilleminault C., Kirisoglu C., and Ohayon M.M. C-reactive protein and sleep-disordered breathing. Sleep 27 (2004) 1507-1511
13. Can M., Acikgoz S., Mungan G., et al. Serum cardiovascular risk factors in obstructive sleep apnea. Chest 129 (2006) 233-237
14. Kobayashi K., Nishimura Y., Shimada T., et al. Effect of continuous positive airway pressure on soluble CD40 ligand in patients with obstructive sleep apnea syndrome. Chest 129 (2006) 632-637
15. Steiropoulos P., Tsara V., Nena E., et al. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest 132 (2007) 843-851
16. Friedman M., Bliznikas D., Vidyasagar R., et al. Reduction of C-reactive protein with surgical treatment of obstructive sleep apnea hypopnea syndrome. Otolaryngol Head Neck Surg 135 (2006) 900-905
17. Kinoshita H., Shibano A., Sakoda T., et al. Uvulopalatopharyngoplasty decreases levels of C-reactive protein in patients with obstructive sleep apnea syndrome. Am Heart J 152 (2006) 692 e1-5
18. Shankar A., Li J., Nieto F.J., et al. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension. Am Heart J 154 (2007) 495-501
19. Danesh J., Whincup P., Walker M., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 (2000) 199-204
20. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
21. Rosenson R.S., and Koenig W. High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease. Curr Opin Cardiol 17 (2002) 325-331
22. Melander O., Newton-Cheh C., Almgren P., et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302 (2009) 49-57
23. Friedman M., Ibrahim H., and Joseph N.J. Staging of obstructive sleep apnea/hypopnea syndrome: a guide to appropriate treatment. Laryngoscope 114 (2004) 454-459
24. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications Australia Pty Limited, 2000. http://www.diabetes.com.au/pdf/obesity_report.pdf Accessed July 4, 2009
25. Chen N.H., Johns M.W., Li H.Y., et al. Validation of a Chinese version of the Epworth Sleepiness Scale. Qual Life Res 11 (2002) 817-821
26. American Academy of Sleep Medicine. Sleep related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22 (1999) 667-689
27. Millerona O., Pillièrea R., Foucher A., et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 25 (2004) 728-734